GNCC Capital, Inc.
$0.00▲ 0.00%(+$0.00)
TickerSpark Score
26/100
▌ Poor
20
Valuation
20
Profitability
20
Growth
40
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNCP research report →
52-Week Range49% of range
Low
$0.00
Current
$0.00
High
$0.00
Company Overviewwww.gncc-capital.com
About the company
GNCC Capital, Inc. , operating through its subsidiary BioCann Pharma S. A.
- CEO
- Nicolaas Edward Blom
- IPO
- 2009
- Employees
- 900
- HQ
- Las Vegas, NV, US
Price Chart
-50.00% · this period
Valuation
- Market Cap
- $8.71M
- P/E
- -6.29
- P/S
- 0.00
- P/B
- -4.76
- EV/EBITDA
- -25.89
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 357.90%
- ROIC
- -15.50%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-555,454 · 6.68%
- EPS
- $0.00 · 0.00%
- Op Income
- $-555,450
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -28.33
- Avg Volume
- 3.37M
Get TickerSpark's AI analysis on GNCP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · GNCP
Our GNCP coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on GNCP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GNCP report →Internal Compare
Similar companies
Peers in the same neighborhood.